$BIIB Headlines Biogen results crush consensus 4:55

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$BIIB Headlines

Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - Russ Britt
Herbalife sinks on probe fears; Zoe’s surges on debut 4:37 p.m. April 11, 2014 - Sue Chang


12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP 3:54 p.m. Aug. 8, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: NTAP, BIIB, USB 12:44 p.m. Aug. 8, 2014 - TheStreet.com
#PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq 6:00 a.m. Aug. 8, 2014 - benzinga.com
#PreMarket Primer: Friday, August 8: U.S. To Begin Airstrikes In Iraq 6:00 a.m. Aug. 8, 2014 - benzinga.com
Sanofi: Confronting Lantus Patent Expiry With More Efficient Successor Toujeo 11:59 a.m. Aug. 7, 2014 - Seeking Alpha
TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis, Reimbursed in Alberta 10:00 a.m. Aug. 7, 2014 - CNW Group
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog 9:10 a.m. Aug. 7, 2014 - Zacks.com
Why Investors Should Closely Watch Celgene 3:53 p.m. Aug. 6, 2014 - benzinga.com
Five Large Caps With Earnings Growth Of 25% Or More 11:46 a.m. Aug. 5, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: MA, UNH, BIIB 11:14 a.m. Aug. 4, 2014 - TheStreet.com
Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog 9:20 a.m. Aug. 4, 2014 - Zacks.com
Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential 7:36 a.m. Aug. 4, 2014 - Seeking Alpha
Biotech Gets A Lift On Popular Drug, Strong Pipeline 6:13 p.m. Aug. 1, 2014 - Investors Business Daily
Stock Market News for August 01, 2014 - Market News 10:10 a.m. Aug. 1, 2014 - Zacks.com
Isis set for milestone payment from Biogen 8:32 a.m. Aug. 1, 2014 - Seeking Alpha
Amgen Makes the Cut 12:25 p.m. July 31, 2014 - Barrons.com
Stock Market News for July 31, 2014 - Market News 10:10 a.m. July 31, 2014 - Zacks.com
Increased Earnings Estimates Seen for Biogen Idec (BIIB): Can It Move Higher? - Tale of the Tape 8:57 a.m. July 31, 2014 - Zacks.com
Biotech Valuations Are Low Not Stretched. Here's Why. 8:35 a.m. July 31, 2014 - TheStreet.com


Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Today - PR Newswire - PRF
The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023 1:00 p.m. Aug. 7, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
BioMed Realty Trust To Webcast Investor Day 2014 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien 9:20 a.m. Aug. 1, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Proteostasis Therapeutics Announces Achievement of Preclinical Milestone in Neurodegenerative Diseases Collaboration With Biogen Idec 5:30 a.m. July 30, 2014 - Marketwire
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept 8:40 a.m. July 17, 2014 - PR Newswire - PRF
Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS) 8:01 a.m. July 16, 2014 - BusinessWire - BZX
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses 5:00 a.m. July 2, 2014 - BusinessWire - BZX
Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014 4:01 p.m. June 30, 2014 - BusinessWire - BZX
Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver 9:31 a.m. June 25, 2014 - PR Newswire - PRF
True North Therapeutics Announces $22 Million Series A Financing 7:00 a.m. June 17, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec 7:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dahua Dives Deep into AIoT at IFA Berlin 2026

Updated Category News Views 1

Dahua's AIoT Vision Unfolds in Berlin Forget the coffee runs and the all-too-dry boardroom discussions—Dahua Technology has taken the stage at IFA Berlin 2026 and they're not just singing the same old tune. They're blasting through innovation barriers with a mix of AIoT—the next-gen tech cocktail everyone’s buzzing about. Leveraging AIoT might sound like...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 2

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 2

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
Labcorp Faces Lawsuit: Wiretapping Accusations Surface

Updated Category News Views 1

Labcorp's Legal Tangle Unveiled One minute you're on Labcorp's website searching for medical info, the next you're caught up in a class-action legal whirlwind. Legal drama is not on any patient’s checklist, but here we are, with Labcorp knee-deep in some serious allegations. The crux of the matter points to alleged wiretapping violations, with claims that Labcorp,...

Continue Reading
XTEND Launches on NYSE Amid Market Milestones

Updated Category News Views 2

XTEND Steps Into the NYSE Spotlight Out of the gate, let's talk about XTEND—a name that's about to make waves on the New York Stock Exchange. With their debut under the ticker XTND, these folks are slamming their flag into the financial terrain like a knight ready for battle. XTEND, an AI-powered defense robotics and software outfit, isn't just joining the party—it's...

Continue Reading
Graywind Redefines Flexibility with New Blinds 2.0

Updated Category News Views 2

Sliding blinds—who knew they'd stir up such a fuss? But here comes Graywind, rolling out their Manual Sliding Track Blinds 2.0, and it's clear they're turning heads in Santa Clara and beyond. This ain't your grandma's drapery setup. We're talking about a sleek, mid-to-premium panel-track system designed to cater to modern living spaces and architectural whimsy. It's...

Continue Reading
AEON's AI-Powered Agentic Checkout: A Game Changer?

Updated Category News Views 5

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

Continue Reading
GlocalMe Unveils Mobile Connectivity Innovations at IFA 2026

Updated Category News Views 3

Stepping into the Connectivity Future at IFA 2026 GlocalMe, a name synonymous with global mobile connections, made a splash at the IFA 2026 in Berlin. Equipped with a lineup built for the future, their presentation focused on lifestyle gadgets designed for constant online access. In a world where digital connection feels as vital as air, they've aligned perfectly with the...

Continue Reading
EF English Live's Approach to Workplace Confidence

Updated Category News Views 3

Pioneering English Confidence for the Global Workplace Stepping into a meeting with international partners requires more than just textbook knowledge of English. It's about confidently expressing ideas, adapting on the fly, and engaging with global colleagues. Enter EF English Live, a leader in transforming workplace communication through targeted English learning. Expert...

Continue Reading
Crocs Steps into Growth Frontier with Confident Strut

Updated Category News Views 2

Crocs' Dance with Destiny at 2026 Growth Frontiers Nothing like stepping into the spotlight, and Crocs, Inc. (NASDAQ: CROX) thinks it's doing just that at Piper Sandler's 2026 Growth Frontiers Conference. A livestream of their presentation is set for September 15, 11:30 AM ET. Now look, this ain’t just a parade of foam clogs and rubber, it’s about solidifying its...

Continue Reading

Top 5 Most Recently Viewed Articles

ZoomInfo Technologies Class Action: Know Your Rights Today

Updated Category News Views 83

Attention Investors: Class Action Lawsuit Filed Against ZoomInfo Technologies For investors in ZoomInfo Technologies, Inc. (NASDAQ: ZI), there’s important news: a major class action lawsuit has been initiated against the company and certain executives. This lawsuit stems from significant financial losses experienced by some investors, marking an essential opportunity...

Continue Reading
Innovative Windshield Wiper Guards Provide Winter Protection

Updated Category News Views 26

Introduction to Windshield Wiper Protectors Winter weather can be harsh on vehicles, especially windshield wipers that endure snow and ice accumulation. An innovative inventor recognized this issue and developed a solution: protective guards for windshield wipers, aptly named WINDSHIELD WIPER PROTECTORS. The goal is simple yet crucial: to keep wipers clean and dry,...

Continue Reading
Farmers and Merchants Bancshares Reports Strong Financial Results

Updated Category News Views 116

Financial Performance Overview Farmers and Merchants Bancshares, Inc. recently announced that its net income for the six months ending in June was $2.4 million, equating to $0.74 per share. This shows a solid performance compared to $2.3 million from the same timeframe the previous year. Importantly, the Company has maintained its return on average equity at 8.18%,...

Continue Reading
Amazon's Stock Performance and Future Growth Potential

Updated Category News Views 215

Amazon's Stock Performance in 2024 Amazon (NASDAQ: AMZN) has been a major force in the market, consistently delivering strong returns for its investors. However, 2024 has posed some challenges, as Amazon's stock has not kept pace with overall market performance. While Amazon's shares have increased by about 17.5% this year, the S&P 500 index has reported a total return of...

Continue Reading
Baird Upgrades Quest Diagnostics Stock Amid Positive Trends

Updated Category News Views 98

Baird Upgrades Quest Diagnostics Stock Amid Positive Trends On a recent Wednesday, Baird, a prominent financial services firm, announced it has upgraded its rating for Quest Diagnostics (NYSE: DGX) stock from Neutral to Outperform. Along with this upgrade, they increased the price target from $157 to an impressive $182. This positive adjustment stems from a bright outlook...

Continue Reading